For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $52.56 in the prior trading day, Doximity Inc (NYSE: DOCS) closed at $53.77, up 2.30%. In other words, the price has increased by $2.30 from its previous closing price. On the day, 4.63 million shares were traded.
Ratios:
Our goal is to gain a better understanding of DOCS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 36.63. For the most recent quarter (mrq), Quick Ratio is recorded 8.67 and its Current Ratio is at 6.97. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on February 07, 2025, Upgraded its rating to Overweight and sets its target price to $78 from $31 previously.
On February 07, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $60 to $90.
On December 20, 2024, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $55.Stephens initiated its Equal-Weight rating on December 20, 2024, with a $55 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 01 ’25 when Wampler Kira Scherer sold 2,000 shares for $56.93 per share. The transaction valued at 113,853 led to the insider holds 16,618 shares of the business.
Bryson Anna sold 50,000 shares of DOCS for $3,000,000 on May 02 ’25. The Chief Financial Officer now owns 357,165 shares after completing the transaction at $60.00 per share. On May 01 ’25, another insider, Bryson Anna, who serves as the Chief Financial Officer of the company, sold 45,000 shares for $57.23 each. As a result, the insider received 2,575,235 and left with 357,165 shares of the company.
Valuation Measures:
As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 48.45, and their Forward P/E ratio for the next fiscal year is 34.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.69 while its Price-to-Book (P/B) ratio in mrq is 9.78.
Stock Price History:
Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $25.00. The 50-Day Moving Average of the stock is -6.91%, while the 200-Day Moving Average is calculated to be 4.02%.
Shares Statistics:
A total of 187.64M shares are outstanding, with a floating share count of 129.60M. Insiders hold about 30.93% of the company’s shares, while institutions hold 67.01% stake in the company.
Earnings Estimates
The dynamic stock of Doximity Inc (DOCS) is currently being evaluated by a team of 14.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.35, with high estimates of $0.45 and low estimates of $0.3.
Analysts are recommending an EPS of between $1.86 and $1.32 for the fiscal current year, implying an average EPS of $1.44. EPS for the following year is $1.61, with 17.0 analysts recommending between $2.13 and $1.47.
Revenue Estimates
15 analysts predict $139.71M in revenue for the current quarter. It ranges from a high estimate of $142.65M to a low estimate of $139.1M. As of the current estimate, Doximity Inc’s year-ago sales were $126.68MFor the next quarter, 15 analysts are estimating revenue of $150.47M. There is a high estimate of $155.3M for the next quarter, whereas the lowest estimate is $145.32M.
A total of 17 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $630.29M, while the lowest revenue estimate was $622.7M, resulting in an average revenue estimate of $626.34M. In the same quarter a year ago, actual revenue was $570.4MBased on 19 analysts’ estimates, the company’s revenue will be $696.39M in the next fiscal year. The high estimate is $730.71M and the low estimate is $675.2M.
